CV, VTE Risk Not Seen in Derm Studies of JAK Inhibitors
'There remains a knowledge gap regarding the risk of JAK inhibitor use and VTE and/or MACE in the dermatologic population,' the study authors wrote.
Source: medscape.com
Page 12 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oint Inflammation Today - Breaking & Trending Today
FDA Approves First Ustekinumab Biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
Source: medscape.com
Trial Shows Precision Medicine in RA 'Remains Elusive'
Histologic analysis did not sufficiently predict treatment response to certain medications, but methods involving gene expression and transcriptome analysis may be more promising.
Source: medscape.com
FastOA Initiative Opens New Paradigm for OA Therapy Trials
A new strategy to test investigational treatments for patients with OA is about to begin in patients who are at risk for accelerated development of OA following ACL reconstructive surgery.
Source: medscape.com
Phenotype-Targeted Treatment Sought for Psoriatic Disease
Researchers described ongoing work to "understand the discrete and overlapping endotypes that underlie the phenotypes" of psoriatic disease and to develop a diagnostic test for psoriatic arthritis.
Source: medscape.com